Invezz
01 Jun 2026, 07:31 UTC · 2h ago
Source · https://invezz.com/news/2026/06/01/bernstein-targets-nifty-at-26000-backs-healthcare-real-estate-industrials/
Read source
Search tags
Story key points
4 claims · impact-rated
Bernstein maintains a year-end Nifty 50 target of 26,000, suggesting approximately 10% upside. — A target indicating moderate growth from current levels provides a bullish baseline for the Indian benchmark index.
+0.30Bernstein recommends overweighting Indian healthcare names like Sun Pharma and Dr Reddy’s due to expected earnings acceleration. — Positive sectoral guidance on specific large-cap names typically drives targeted buying interest in those stocks.
+0.30Bernstein identifies L&T and Siemens India as attractive plays on AI and data-center infrastructure spending. — Positive outlook on industrials tied to the AI capex trend supports growth expectations for these specific companies.
+0.20Continue reading
6 related stories
Bernstein retains a 'Neutral' overall stance on Indian equities, citing weak macroeconomic conditions and earnings downgrades. — A neutral rating from a major brokerage signals a lack of high-conviction bullishness, tempering aggressive risk appetite.
Ticker attribution
Model heads
Recommended as an 'add/overweight' pick with expected earnings acceleration.
Highlighted as an attractive pick due to ongoing AI and data-centre infrastructure spend.
Highlighted as an attractive pick due to ongoing AI and data-centre infrastructure spend.
No ticker relationship head found.
Impact vectors
10 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Proactive Investors
2h ago
